McCloskey RV - Search Results

1

Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group.

Sprung CL, Eidelman LA, Pizov R, Fisher CJ Jr, Ziegler EJ, Sadoff JC, Straube RC, McCloskey RV. Sprung CL, et al. Among authors: mccloskey rv. Crit Care Med. 1997 Mar;25(3):383-7. doi: 10.1097/00003246-199703000-00002. Crit Care Med. 1997. PMID: 9118650

2

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR. McCloskey RV, et al. Ann Intern Med. 1994 Jul 1;121(1):1-5. doi: 10.7326/0003-4819-121-1-199407010-00001. Ann Intern Med. 1994. PMID: 8198341 Clinical Trial.

3

Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.

Derkx B, Wittes J, McCloskey R. Derkx B, et al. Clin Infect Dis. 1999 Apr;28(4):770-7. doi: 10.1086/515184. Clin Infect Dis. 1999. PMID: 10825037 Clinical Trial.

4

Topical antimicrobial agents and antibiotics for the eye.

McCloskey RV. McCloskey RV. Med Clin North Am. 1988 May;72(3):717-22. doi: 10.1016/s0025-7125(16)30767-2. Med Clin North Am. 1988. PMID: 3280915 Free article. Review.

5

Antibiotics.

McCloskey RV. McCloskey RV. Clin Anesth. 1974;10(1):283-98. Clin Anesth. 1974. PMID: 4360083 Review. No abstract available.

6

Creating therapeutic proteins from bioengineered systems.

McCloskey RV. McCloskey RV. Biotechnol Healthc. 2004 Sep;1(4):57-61. Biotechnol Healthc. 2004. PMID: 23393440 Free PMC article.

7

Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.

Ohshima S, Mima T, Sasai M, Nishioka K, Shimizu M, Murata N, Yoshikawa H, Nakanishi K, Suemura M, McCloskey RV, Kishimoto T, Saeki Y. Ohshima S, et al. Among authors: mccloskey rv. Cytokine. 2000 Mar;12(3):281-8. doi: 10.1006/cyto.1999.0552. Cytokine. 2000. PMID: 10704256

8

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN. Paleolog EM, et al. Among authors: mccloskey rv. Arthritis Rheum. 1998 Jul;41(7):1258-65. doi: 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1. Arthritis Rheum. 1998. PMID: 9663484 Clinical Trial.

9

Heparin-induced skin necrosis.

McCloskey RV. McCloskey RV. N Engl J Med. 1997 Feb 20;336(8):588; author reply 589. doi: 10.1056/NEJM199702203360817. N Engl J Med. 1997. PMID: 9036315 No abstract available.

10

Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.

Walker RE, Spooner KM, Kelly G, McCloskey RV, Woody JN, Falloon J, Baseler M, Piscitelli SC, Davey RT Jr, Polis MA, Kovacs JA, Masur H, Lane HC. Walker RE, et al. Among authors: mccloskey rv. J Infect Dis. 1996 Jul;174(1):63-8. doi: 10.1093/infdis/174.1.63. J Infect Dis. 1996. PMID: 8656014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters